Delivery Order SPE2DB20D3103-SPE2DB25FP9Y3
- Not listed
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on August 19, 2025. The contract, designated as a non-set-aside competitive award, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,967.70 delivery order to Amerisourcebergen Drug Corporation for Kineret 100 mg/0.67 ml syringes. The firm fixed price order is for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania, and has a period of performance from August 24, 2023 through September 15, 2023. As a major supplier of medical materiel to the U.S. Department of Defense, the Defense Logistics Agency utilizes contracts such as Amerisourcebergen's...
- Amerisourcebergen Drug Corporation, operating from its Conshohocken, Pennsylvania corporate office, has been awarded a $7,141.86 firm fixed price delivery order contract from the Defense Logistics Agency Troop Support Medical to provide 4562493042 Kineret 100 mg/0.67 ml syringes. The contract has no set-aside designation and requires delivery of the specified pharmaceutical by November 6, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and...
- This is a $7,161.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KINERET 100 MG/0.67 ML SYRINGE 0.67ML medical products, with a period of performance through April 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the delivery of 4,564,159,150 units of the specialty pharmaceutical drug Kineret 100 mg/0.67 ml syringe. The contract has a firm fixed price and is a delivery order with an ultimate completion date of April 24, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Kineret 100 mg/0.67 ml syringes. The fixed-price contract, valued at $4,476.10, has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9Y3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a contract ceiling value of $7,161.76 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through DLA, supplying a broad portfolio of pharmaceutical products and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract history demonstrates consistent capability in delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular order for Kineret—a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions—aligns with the company's established role as a critical vendor for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/22/25 |